{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:25:59Z","timestamp":1792794359519,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jid.2024.09.012","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T18:11:19Z","timestamp":1729620679000},"page":"2645-2649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Curing Psoriasis"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-3675","authenticated-orcid":false,"given":"Su M.","family":"Lwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1094-7113","authenticated-orcid":false,"given":"Shir","family":"Azrielant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3933-0563","authenticated-orcid":false,"given":"Juan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-4427","authenticated-orcid":false,"given":"Christopher E.M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2024.09.012_bib1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s41409-022-01702-w","article-title":"Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)","volume":"57","author":"Alexander","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jid.2024.09.012_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jid.2023.06.077","article-title":"LB1703 High induction dosing of Risankizumab in patients with moderate-to-severe plaque psoriasis: interim results from the phase 2 KNOCKOUT study","volume":"143","author":"Blauvelt","year":"2023","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.09.012_bib3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41591-024-02964-1","article-title":"Bispecific T cell engager therapy for refractory rheumatoid arthritis","volume":"30","author":"Bucci","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2024.09.012_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-022-01059-y","article-title":"Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1\/2a, single-arm study","volume":"7","author":"Cheng","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jid.2024.09.012_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/LVUQ5853","article-title":"Identifying and managing psoriasis-associated comorbidities: the IMPACT research programme","volume":"10","author":"Cordingley","year":"2022","journal-title":"Programme Grants Appl Res"},{"key":"10.1016\/j.jid.2024.09.012_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/art.40737","article-title":"Adoptive Treg cell therapy in a patient with systemic lupus erythematosus","volume":"71","author":"Dall\u2019Era","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2024.09.012_bib7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41467-024-44994-w","article-title":"Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade","volume":"15","author":"Francis","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2024.09.012_bib8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41423-023-01018-9","article-title":"The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair","volume":"20","author":"Giacomini","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jid.2024.09.012_bib9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2024.09.012_bib10","first-page":"613","article-title":"A\u00a0personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory","volume":"29","author":"Hood","year":"2012","journal-title":"N\u00a0Biotechnol"},{"key":"10.1016\/j.jid.2024.09.012_bib11","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/jdv.18846","article-title":"Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study","volume":"37","author":"Iversen","year":"2023","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.09.012_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1005115","article-title":"The imbalance between type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris","volume":"13","author":"Kim","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.09.012_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2015.01.018","article-title":"Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial","volume":"136","author":"Krueger","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2024.09.012_bib14","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjd.20517","article-title":"The promise and challenges of cell therapy for psoriasis","volume":"185","author":"Lwin","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.09.012_bib15","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2024.09.012_bib16","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/genes14081619","article-title":"Genetic and epigenetic mechanisms of psoriasis","volume":"14","author":"Mateu-Arrom","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jid.2024.09.012_bib17","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1172\/JCI93396","article-title":"Clinically resolved psoriatic lesions contain psoriasis-specific IL-17\u2013producing \u03b1\u03b2 T cell clones","volume":"127","author":"Matos","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2024.09.012_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.09.012_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01572-0","article-title":"HLA-G gene editing in tumor cell lines as a novel alternative in cancer immunotherapy","volume":"11","author":"Palma","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2024.09.012_bib20","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1038\/s41467-022-34323-4","article-title":"Shared genetic risk factors and causal association between psoriasis and coronary artery disease","volume":"13","author":"Patrick","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2024.09.012_bib21","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s10753-023-01883-6","article-title":"Low-dose interleukin-2 for psoriasis therapy based on the regulation of Th17\/Treg cell balance in peripheral blood","volume":"46","author":"Qiao","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.jid.2024.09.012_bib22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/bjd.21242","article-title":"A\u00a0rapid access clinic for psoriasis: first experiences","volume":"187","author":"Reid","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.09.012_bib23","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jdv.19236","article-title":"Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study","volume":"37","author":"Sch\u00e4kel","year":"2023","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.09.012_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jid.2024.09.012_bib25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjd.17748","article-title":"CD8 resident memory T cells with interleukin 17A-producing potential are accumulated in disease-na\u00efve nonlesional sites of psoriasis possibly in correlation with disease duration","volume":"181","author":"Vo","year":"2019","journal-title":"Br J Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24021614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24021614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T01:06:27Z","timestamp":1764551187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X24021614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0022202X24021614"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2024.09.012","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curing Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2024.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}